Antleron

Foundation date

2014

Sector

#Biotechnology / R&D Services

Therapeutic areas

We are Antleron, a nimble team that will revolutionise medicine by leading the development of next generation advanced therapies and medical devices. By merging the potential of cells, biomaterials, biologics, 3D printing and bioreactors we will accelerate the engineering of medicinal products, devices and processes that will change health care and result in a better life for all. The Antleron business philosophy is to create sustainable ventures through risk & reward sharing partnerships.

Upcoming events

Latest news

  • miDiagnostics to pilot innovative, fast COVID-19 PCR testing solutions at Brussels Airport

    14 hours ago

  • VIB celebrates 25 years of groundbreaking research

    Wednesday October 13th 2021

  • Oxurion NV announces first patient dosed in its Phase 2 Study evaluating THR-687 for the treatment of Diabetic Macular Edema (DME)

    Wednesday October 13th 2021